UiPath hits an inflection point with stabilizing SaaS, AI roadmap, Maestro platform upsells, top partnerships, and clean ...

Once thought to be doomed by the AI revolution, robotic process automation specialist UiPath ( PATH +2.94%) defied critics in ...

UiPath delivered a beat-and-raise quarter and was promoted into a midcap index. Shares of automation software company UiPath ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Wondering if UiPath is still a smart way to play the AI and automation theme, or if the easy money has already been made? Here is a look at the numbers so you can decide if the current price really ...

UiPath (PATH) just checked several key boxes for investors at once, moving from GAAP losses to profit while accelerating revenue growth and doubling down on its agentic AI and automation platform ...

UiPath Inc. (PATH) is one of a bunch of software companies that went public in 2021, saw its shares subsequently collapse, and have seemingly never managed to make a recovery. And to be fair, many of ...

CEO and Chairman, Dines Daniel, sold shares worth around $1.5 million earlier in the week. ・He sold 90,000 shares of the ...

Independent survey of finance, revenue cycle, and clinical operations leaders recognizes XiFin's leadership as AI becomes essential to denial prevention, payor policy navigation, and financial ...

(MENAFN- Frost & Sullivan) RapidClaims Receives Frost & Sullivan's 2025 North American Healthcare IT-Software and Services Technology Innovation Leadership Recognition for Excellence in AI-Driven RCM ...